A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA ...

A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

Cancer does not appear overnight, but is built over years of poor diet and lifestyle. Dr Vishwani shares 5 foods that ...

Memorial Sloan Kettering Cancer Center investigators and collaborators have tested rezatapopt, an oral p53 reactivator ...

Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...

Research from the University of Warwick suggests that many AI systems may be using visual shortcuts rather than true biology, ...

The researchers identified seven driver genes responsible for tumour development when mutated. The most common was FBXW7, altered in over half of feline mammary tumours. In human breast cancer, ...

University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden ...

A Lafayette father's battle with stage 4 pancreatic cancer is taking a hopeful turn as he becomes the first in Colorado to receive a newly approved targeted therapy.

Active surveillance (“watch and wait”) functioned as a strategy to monitor biology while preserving sequencing flexibility for subsequent therapies. Living long-term with cancer means learning to live ...

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

Blood tests are the most common way for health professionals to detect and diagnose a range of medical conditions. But can it ...